DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 190 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $71 | -2.7% | 4,522 | 0.0% | 0.00% | – |
Q4 2023 | $73 | -93.1% | 4,522 | -80.9% | 0.00% | -100.0% |
Q3 2023 | $1,060 | +1556.2% | 23,710 | +424.3% | 0.00% | – |
Q2 2023 | $64 | -8.6% | 4,522 | 0.0% | 0.00% | – |
Q1 2023 | $70 | -5.4% | 4,522 | 0.0% | 0.00% | – |
Q4 2022 | $74 | -99.9% | 4,522 | 0.0% | 0.00% | – |
Q3 2022 | $84,000 | +42.4% | 4,522 | 0.0% | 0.00% | – |
Q2 2022 | $59,000 | +40.5% | 4,522 | 0.0% | 0.00% | – |
Q1 2022 | $42,000 | -4.5% | 4,522 | 0.0% | 0.00% | – |
Q4 2021 | $44,000 | -71.4% | 4,522 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $154,000 | -7.2% | 4,522 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $166,000 | -18.2% | 4,522 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $203,000 | -21.3% | 4,522 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $258,000 | +11.2% | 4,522 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $232,000 | -14.1% | 4,522 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $270,000 | +45.2% | 4,522 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $186,000 | – | 4,522 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |